Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19

Abstract

The results obtained in this study show that using PPIs for more than 4 weeks is associated with negative outcomes for patients with COVID-19. Patients receiving PPI therapy should be evaluated more carefully if they are hospitalized for COVID-19 treatment.